Panel Discusses Growing Use of GLP-1s Beyond Traditional Target Population Panelist Alaina Vidmar, MD, DABOM, previews a session on health considerations in GLP-1 therapy at different ages. Kelly Harkins2026-11-15T11:45:14-05:00November 15th, 2026|